News

Many congratulations to Amy Bates, Research Radiographer for the VoxTox project, who won second prize for her poster at the cancer research conference for the NIHR Eastern clinical research network. 

Amy also won a highly commended award for cancer research excellence (non medical). 

The poster was titled "Acute toxicity with helical image guided IMRT for head & neck cancer: unilateral versus bilateral nodal irradiation", authors A.M. Bates, D.J. Noble, O. Young, E. Wong, J. Gemmill, R.J. Benson, S.J. Jefferies, G.G. Barnett, N.G. Burnet.

Agora-RT

Glioblastoma Multiforme (GBM) is one of the most common – and most aggressive – of brain cancers, responsible for more years of life lost per patient than any other common adult cancer. GBM tumours show rapid and extensive microscopic infiltration of tumour cells away from the primary disease site and into normal brain tissue; making combination treatment with surgery, radiotherapy and chemotherapy challenging and overall medial survival extremely poor.

VoxTox animation thumbnail

The animation shows a man with prostate cancer who lies down on the treatment machine. On the treatment machine itself he will have a CT scan done each day and these scans are used in our VoxTox programme.

Dr David Noble

Dr David Noble has recently joined the VoxTox team after being awarded a research fellowship from the Addenbrooke's Charitable Trust.

Presentations from the CompRT Symposium held in June 2015 can be found below. Details of the 2016 symposium will be announced in due course.

Rectal imaging - VoxTox

Dr Jessica Scaife has been awarded a highly commended prize in the UKRO 2015 proffered paper competition, for her paper "Late rectal toxicity following prostate radiotherapy with helical tomotherapy".

Our Computational Radiotherapy Symposium in Cambridge was held on Wednesday 17th June, 2015. The flyer shows the programme; we will post links here to the presentations as they become available

We are pleased to announce that Jessica Scaife, Clinical Research Fellow working on the Cancer Research UK VoxTox Programme, has been awarded the Helen Patterson Award for Registrar Research 2014 by the British Uro-oncology Group (BUG). This is in recognition of her winning presentation at the BUG Annual Meeting on 13th September 2014. We are particularly delighted at the prize since Helen Patterson was a much respected consultant colleague in our department.